Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 16729-045, ATORVASTATIN CALCIUM, tablet, film coated, from Accord Healthcare Inc..

Product NDC
16729-045
Status
Listed
Labeler
Accord Healthcare Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207687
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
16729-045-151672900451590 TABLET, FILM COATED in 1 BOTTLE (16729-045-15)
16729-045-17167290045171000 TABLET, FILM COATED in 1 BOTTLE (16729-045-17)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4e06b20d-cc5d-46eb-991b-5972248de3af

Use it

Look up 16729-045 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.